RPE adenocarcinoma arising from a congenital hypertrophy of the RPE (CHRPE) treated with proton therapy.
Department of Ophthalmology, University of Lausanne, Jules-Gonin Eye Hospital, FAA, Lausanne, Switzerland.
A P
AP
Moulin
Department of Ophthalmology, University of Lausanne, Jules-Gonin Eye Hospital, FAA, Lausanne, Switzerland.
L
L
Zografos
Department of Ophthalmology, University of Lausanne, Jules-Gonin Eye Hospital, FAA, Lausanne, Switzerland.
A
A
Schalenbourg
D000230:Adenocarcinoma / Q000209:etiology* / Q000473:pathology / Q000532:radiotherapy*; D006801:Humans; D006984:Hypertrophy / Q000151:congenital / Q000473:pathology / Q000532:radiotherapy; D008297:Male; D008875:Middle Aged; D061766:Proton Therapy; D011882:Radiotherapy, High-Energy / Q000379:methods*; D019572:Retinal Neoplasms / Q000209:etiology* / Q000473:pathology / Q000532:radiotherapy*; D055213:Retinal Pigment Epithelium / Q000473:pathology* / Q000528:radiation effects; D016896:Treatment Outcome; D011522:Protons
D011522:Protons